ANAHEIM, CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that Joseph J. Galligan was appointed to the Company’s Board of Directors.
Copyright © 2021 Biotech Networks, LLC
